Merck spends $11.5B for Acceleron, possible blockbuster drug Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart. Sep 30, 2021 0 1
Toxic DNA buildup in eyes may drive blinding macular degeneration Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the University of Virginia School ... Sep 30, 2021 0 146
Breastfeeding status and duration significantly impact postpartum depression risk According to the United States Centers for Disease Control and Prevention, between 11 and 20 percent of women who give birth each year in the U.S. have postpartum depression symptoms, which is the greatest risk factor for ... Sep 30, 2021 0 2
Ukraine reports highest daily COVID cases since April Ukraine on Thursday reported its highest number of daily coronavirus cases since April as authorities prepared to introduce compulsory vaccinations for teachers and government officials. Sep 30, 2021 0 4
Revising theory of cancer-induced immune suppression Many cancers produce an enzyme called IDO that suppresses immune system activity, but the long-held hypothesis of how this mechanism operates requires revision, according to a study published in Clinical Cancer Research. Sep 30, 2021 0 39
Genetic risks for depression differ between East Asian and European groups Specific genes increase the risk of developing depression, according to a new study led by UCL researchers, which also shows that the genes associated with depression vary depending on ancestry group. Sep 30, 2021 0 84
Type 2 diabetes drug trial uses patient experience to find their best drug An innovative trial which invited people to take three drugs in turn, then choose their preferred option, has generated insights into which type 2 diabetes drug is best to prescribe to individuals. Sep 30, 2021 0 2
Novel approach to 3D image segmentation delivers 'jaw-dropping' demonstration Skoltech researchers led by Professor Dylov and their colleagues from First Pavlov State Medical University of St. Petersburg, Russia, have developed a brand-new approach to the task of 3D image segmentation—figuring out ... Sep 30, 2021 0 2
What history can teach us about pandemic management While the word "unprecedented" has become part of the rhetoric around COVID-19, this isn't the first pandemic to hit the world, even in recent times. In fact, there are many similarities between the COVID-19 pandemic, and ... Sep 30, 2021 0 7
New treatment uses reverse vaccination to teach immune system not to attack life-saving drugs For nearly a third of patients with hemophilia A and almost all patients with Pompe disease, their own immune system is their greatest obstacle to treatment. When given essential proteins and enzymes, their body perceives ... Sep 30, 2021 0 66